A trial looking at the treatment of SOF/GS-5816 for 12 weeks in patients with hepatitis C infection

Update Il y a 4 ans
Reference: EUCTR2014-001683-35

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objectives of this study are: - To evaluate the efficacy of treatment with SOF/GS-5816 for 12 weeks in subjects with chronic HCV infection as measured by the proportion of subjects with SVR12 - To evaluate the safety and tolerability of treatment with SOF/GS-5816 for 12 weeks


Inclusion criteria

  • Chronic hepatitis C virus infection